Journal: Neuron
Article Title: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
doi: 10.1016/j.neuron.2024.06.002
Figure Lengend Snippet: (A) Cartoon of U2OS model harboring pB-SNCA-3K-sfGFP transgene. Micrographs show transgene GFP signal in doxycycline-treated cells. (B) Genome-wide CRISPR-Cas9 knockout screen for modifiers of αS toxicity. (C) Volcano plot showing depletion of essential genes (blue). (D) Volcano plot comparing fold-change differential between SNCA-3K-sfGFP and SNCA-WT-sfGFP genotypes. (E) Overlap between spatial (APEX2 and MYTH) and genetic (CRISPR) screen hits. (F) Interaction of actin cytoskeleton-related proteins RhoA and RhoBTB3 with αS by MYTH. (G) Left, Kaplan-Meier curve of single-cell survival tracking in pi-N 3K-sfGFP-pB and pi-N sfGFP-pB models transduced with shRNA lentivirus. Log rank test: *** p < 0.001, **** p < 0.0001. Data are representative of 2 neuronal differentiations with shRNA lentivirus at MOI20. Right, neurite measurement based on RFP signal. (H) PLA of RhoA-pS129 in inclusionopathy models. Bottom, quantification of pS129(+) soma-type inclusions from 3 to 4 independent replicates across 3 separate neuronal differentiations. One-way ANOVA plus Tukey’s multiple comparison test: **** p < 0.0001; n.s., not significant. (I) IF for RhoA, p62, and αS in A53T ( n = 2), E46K ( n = 2), and sporadic ( n = 11) PD brain. Orange arrow, αS(+)/p62(+)/RhoA(+) inclusion; white arrow, αS(+)/p62(+)/RhoA(−) inclusion. (J) Left, quantification of pS129(+)/RhoA(+) inclusions in PD brain. Right, quantification of (I). Error bars = SD.
Article Snippet: We developed algorithms for single-cell inclusion survival tracking with longitudinal imaging (BioStation CT, Nikon) for both spontaneous and seeded inclusionopathy models ( – ).
Techniques: Genome Wide, CRISPR, Knock-Out, Transduction, shRNA, Comparison